AI-Enabled Device Allows Novices to Accurately Estimate Gestational Age
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 6, 2024 -- Novice users with no prior training in ultrasonography can accurately estimate gestational age (GA) with an artificial intelligence (AI)-enabled device for first-trimester pregnancies, according to a study published online Aug. 1 in the Journal of the American Medical Association.
Jeffrey S.A. Stringer, M.D., from the University of North Carolina School of Medicine in Chapel Hill, and colleagues examined GA estimation accuracy of an AI-enabled ultrasonography tool when used by novices with no prior sonography training. The prospective diagnostic accuracy study enrolled 400 individuals with viable, single, nonanomalous first-trimester pregnancies. Credentialed sonographers established the “ground truth” GA. Novice users obtained blind sweeps of the maternal abdomen using the AI-enabled device (index test) at random follow-up visits throughout gestation, including a primary evaluation window (from 14 0/7 weeks to 27 6/7 weeks of gestation), and credentialed sonographers performed fetal biometry with a high-specification machine (study standard).
The researchers found that the AI-enabled device met criteria for equivalence to the study standard in the primary evaluation window, with a mean absolute error of 3.2 versus 3.0 days. The percentage of assessments within seven days of the "ground truth" GA was comparable (90.7 versus 92.5 percent for the index test and study standard, respectively). In prespecified subgroups, including those with high body mass index, performance was consistent.
"These findings have immediate implications for obstetrical care in low-resource settings, advancing the World Health Organization goal of ultrasonography estimation of GA for all pregnant people," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-07 01:15
Read more
- Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
- FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
- Heat Waves Linked to Adverse Health Outcomes for Seniors
- Orexo initiates new study of OX640 in participants with allergic rhiniti
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions